Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Aug;88(2):379–384. doi: 10.1172/JCI115314

Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells.

R A Brooimans 1, A P Stegmann 1, W T van Dorp 1, A A van der Ark 1, F J van der Woude 1, L A van Es 1, M R Daha 1
PMCID: PMC295341  PMID: 1864952

Abstract

Previous reports have suggested the production of complement components C4, C2, and factor B by renal tissue. However, the cells involved in production of complement have not been identified. In this study metabolic labeling experiments demonstrated that human proximal tubular epithelial cells (PTEC) synthesize a 180-kD precursor of C3 that is secreted after proteolytic cleavage into a disulphide linked two-chain molecule as found in plasma. C3 present in culture supernatants of PTEC was functionally active, however, during the culture period there was a partial inactivation of the C3 molecule as assessed by hemolytic titration. Recombinant IL-2 enhances the rate of C3 synthesis in a dose-dependent manner reaching maximal stimulation at doses of 200-400 U/ml IL-2. Northern blot analysis demonstrated a 5.2-kb C3 mRNA species present in PTEC that was increased within 24 h of IL-2 treatment. IL-2-induced enhancement of C3 production by PTEC could be neutralized with specific antibodies to IL-2. This study demonstrates that C3 synthesis in PTEC is upregulated by IL-2, the major cytokine produced by activated T cells.

Full text

PDF
379

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Johnson A. M., Birtch A. G., Moore F. D. Human C'3: evidence for the liver as the primary site of synthesis. Science. 1969 Jan 17;163(3864):286–288. doi: 10.1126/science.163.3864.286. [DOI] [PubMed] [Google Scholar]
  2. Atkins M. B., Gould J. A., Allegretta M., Li J. J., Dempsey R. A., Rudders R. A., Parkinson D. R., Reichlin S., Mier J. W. Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease. J Clin Oncol. 1986 Sep;4(9):1380–1391. doi: 10.1200/JCO.1986.4.9.1380. [DOI] [PubMed] [Google Scholar]
  3. Beatty D. W., Davis A. E., 3rd, Cole F. S., Einstein L. P., Colten H. R. Biosynthesis of complement by human monocytes. Clin Immunol Immunopathol. 1981 Mar;18(3):334–343. doi: 10.1016/0090-1229(81)90126-4. [DOI] [PubMed] [Google Scholar]
  4. Brooimans R. A., Hiemstra P. S., van der Ark A. A., Sim R. B., van Es L. A., Daha M. R. Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma. J Immunol. 1989 Mar 15;142(6):2024–2030. [PubMed] [Google Scholar]
  5. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  6. Cole F. S., Auerbach H. S., Goldberger G., Colten H. R. Tissue-specific pretranslational regulation of complement production in human mononuclear phagocytes. J Immunol. 1985 Apr;134(4):2610–2616. [PubMed] [Google Scholar]
  7. Detrisac C. J., Sens M. A., Garvin A. J., Spicer S. S., Sens D. A. Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int. 1984 Feb;25(2):383–390. doi: 10.1038/ki.1984.28. [DOI] [PubMed] [Google Scholar]
  8. Espinoza-Delgado I., Ortaldo J. R., Winkler-Pickett R., Sugamura K., Varesio L., Longo D. L. Expression and role of p75 interleukin 2 receptor on human monocytes. J Exp Med. 1990 May 1;171(5):1821–1826. doi: 10.1084/jem.171.5.1821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  10. Feucht H. E., Zwirner J., Bevec D., Lang M., Felber E., Riethmüller G., Weiss E. H. Biosynthesis of complement C4 messenger RNA in normal human kidney. Nephron. 1989;53(4):338–342. doi: 10.1159/000185778. [DOI] [PubMed] [Google Scholar]
  11. Hack C. E., Paardekooper J., Smeenk R. J., Abbink J., Eerenberg A. J., Nuijens J. H. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies. J Immunol. 1988 Sep 1;141(5):1602–1609. [PubMed] [Google Scholar]
  12. Handa K., Suzuki R., Matsui H., Shimizu Y., Kumagai K. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production. J Immunol. 1983 Feb;130(2):988–992. [PubMed] [Google Scholar]
  13. Hinglais N., Kazatchkine M. D., Bhakdi S., Appay M. D., Mandet C., Grossetete J., Bariety J. Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Kidney Int. 1986 Sep;30(3):399–410. doi: 10.1038/ki.1986.198. [DOI] [PubMed] [Google Scholar]
  14. Johnson E., Hetland G. Mononuclear phagocytes have the potential to synthesize the complete functional complement system. Scand J Immunol. 1988 May;27(5):489–493. doi: 10.1111/j.1365-3083.1988.tb02375.x. [DOI] [PubMed] [Google Scholar]
  15. Katz Y., Revel M., Strunk R. C. Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts. Eur J Immunol. 1989 Jun;19(6):983–988. doi: 10.1002/eji.1830190605. [DOI] [PubMed] [Google Scholar]
  16. Katz Y., Strunk R. C. Synovial fibroblast-like cells synthesize seven proteins of the complement system. Arthritis Rheum. 1988 Nov;31(11):1365–1370. doi: 10.1002/art.1780311104. [DOI] [PubMed] [Google Scholar]
  17. Lambris J. D. The multifunctional role of C3, the third component of complement. Immunol Today. 1988 Dec;9(12):387–393. doi: 10.1016/0167-5699(88)91240-6. [DOI] [PubMed] [Google Scholar]
  18. Mier J. W., Dinarello C. A., Atkins M. B., Punsal P. I., Perlmutter D. H. Regulation of hepatic acute phase protein synthesis by products of interleukin 2 (IL 2)-stimulated human peripheral blood mononuclear cells. J Immunol. 1987 Aug 15;139(4):1268–1272. [PubMed] [Google Scholar]
  19. Miltenburg A. M., Meijer-Paape M. E., Daha M. R., van Bockel J. H., Weening J. J., van Es L. A., van der Woude F. J. Donor-specific lysis of human kidney proximal tubular epithelial cells by renal allograft-infiltrating lymphocytes. Transplantation. 1989 Aug;48(2):296–302. doi: 10.1097/00007890-198908000-00022. [DOI] [PubMed] [Google Scholar]
  20. Morris K. M., Colten H. R., Bing D. H. The first component of complement. A quantitative comparison of its biosynthesis in culture by human epithelial and mesenchymal cells. J Exp Med. 1978 Oct 1;148(4):1007–1019. doi: 10.1084/jem.148.4.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Morris K. M., Goldberger G., Colten H. R., Aden D. P., Knowles B. B. Biosynthesis and processing of a human precursor complement protein, pro-C3, in a hepatoma-derived cell line. Science. 1982 Jan 22;215(4531):399–400. doi: 10.1126/science.7199205. [DOI] [PubMed] [Google Scholar]
  22. Nedwin G. E., Svedersky L. P., Bringman T. S., Palladino M. A., Jr, Goeddel D. V. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta. J Immunol. 1985 Oct;135(4):2492–2497. [PubMed] [Google Scholar]
  23. Passwell J., Schreiner G. F., Nonaka M., Beuscher H. U., Colten H. R. Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis. J Clin Invest. 1988 Nov;82(5):1676–1684. doi: 10.1172/JCI113780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Preffer F. I., Colvin R. B., Leary C. P., Boyle L. A., Tuazon T. V., Lazarovits A. I., Cosimi A. B., Kurnick J. T. Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+3+ subpopulation. J Immunol. 1986 Nov 1;137(9):2823–2830. [PubMed] [Google Scholar]
  25. Roord J. J., Daha M., Kuis W., Verbrugh H. A., Verhoef J., Zegers B. J., Stoop J. W. Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family. Pediatrics. 1983 Jan;71(1):81–87. [PubMed] [Google Scholar]
  26. Sim R. B., Sim E. Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin. Biochem J. 1981 Jan 1;193(1):129–141. doi: 10.1042/bj1930129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Strunk R. C., Eidlen D. M., Mason R. J. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest. 1988 May;81(5):1419–1426. doi: 10.1172/JCI113472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tack B. F., Morris S. C., Prahl J. W. Third component of human complement: structural analysis of the polypeptide chains of C3 and C3b. Biochemistry. 1979 Apr 17;18(8):1497–1503. doi: 10.1021/bi00575a017. [DOI] [PubMed] [Google Scholar]
  29. Ueki A., Sai T., Oka H., Tabata M., Hosokawa K., Mochizuki Y. Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro. Immunology. 1987 May;61(1):11–14. [PMC free article] [PubMed] [Google Scholar]
  30. Waldmann T. A. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science. 1986 May 9;232(4751):727–732. doi: 10.1126/science.3008337. [DOI] [PubMed] [Google Scholar]
  31. Warren H. B., Pantazis P., Davies P. F. The third component of complement is transcribed and secreted by cultured human endothelial cells. Am J Pathol. 1987 Oct;129(1):9–13. [PMC free article] [PubMed] [Google Scholar]
  32. Whaley K. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med. 1980 Mar 1;151(3):501–516. doi: 10.1084/jem.151.3.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zwirner J., Felber E., Herzog V., Riethmüller G., Feucht H. E. Classical pathway of complement activation in normal and diseased human glomeruli. Kidney Int. 1989 Dec;36(6):1069–1077. doi: 10.1038/ki.1989.302. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES